New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Rethinking how cancer immunotherapy drugs are delivered could save millions

Rethinking how cancer immunotherapy drugs are delivered could save millions

A new analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.
World medicine November 19,2023
Rethinking how cancer immunotherapy drugs are delivered could save millions

Rethinking how cancer immunotherapy drugs are delivered could save millions

A new analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.
World medicine November 19,2023
Researchers develop 3D bioprinting technology for eliminating cancer cells

Researchers develop 3D bioprinting technology for eliminating cancer cells

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.Through joint research with th
World medicine November 19,2023
Researchers develop 3D bioprinting technology for eliminating cancer cells

Researchers develop 3D bioprinting technology for eliminating cancer cells

A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for the first time in the world.Through joint research with th
World medicine November 19,2023
Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

A new research paper was published inOncotarget'sVolume 14 on July 7, 2023, entitled, "Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squ
World medicine November 19,2023
Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

A new research paper was published inOncotarget'sVolume 14 on July 7, 2023, entitled, "Effectiveness and toxicity of cetuximab with concurrent RT in locally advanced cutaneous squ
World medicine November 19,2023
Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Health care providers and their patients could know with greater confidence whether pancreatic cysts are benign or potentially malignant, and if surgery is required to remove them, by using a new diag
World medicine November 19,2023
Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Amplified Sciences secures $400,000 grant to develop pancreatic cancer diagnostic test

Health care providers and their patients could know with greater confidence whether pancreatic cysts are benign or potentially malignant, and if surgery is required to remove them, by using a new diag
World medicine November 19,2023
Light-powered technology could guide immune cells to infections and cancer

Light-powered technology could guide immune cells to infections and cancer

The immune system's ability to send its army of immune cells to the right location with the right level of response is key to the body's ability to fight an infection or a growing tumor. An in
World medicine November 19,2023
Light-powered technology could guide immune cells to infections and cancer

Light-powered technology could guide immune cells to infections and cancer

The immune system's ability to send its army of immune cells to the right location with the right level of response is key to the body's ability to fight an infection or a growing tumor. An in
World medicine November 19,2023
Researchers develop first therapy of its kind to treat cisplatin-resistant prostate cancer

Researchers develop first therapy of its kind to treat cisplatin-resistant prostate cancer

Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy medications -; cisplatin. Now, researchers reporting inACS Central
World medicine November 19,2023
Researchers develop first therapy of its kind to treat cisplatin-resistant prostate cancer

Researchers develop first therapy of its kind to treat cisplatin-resistant prostate cancer

Prostate cancer is a leading cause of death among American men, and it's resistant to one of the most powerful chemotherapy medications -; cisplatin. Now, researchers reporting inACS Central
World medicine November 19,2023
UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a
Oncology November 19,2023
UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

UCLA researchers confirm mutations that predispose patients to rare kidney cancer syndrome

Researchers at the UCLA Jonsson Comprehensive Cancer Center have confirmed that a large number of genetic variants of unknown significance are in fact verified mutations that predispose patients to a
Oncology November 19,2023
Synoptic reports improve completeness of pretreatment CT reports in advanced ovarian cancer

Synoptic reports improve completeness of pretreatment CT reports in advanced ovarian cancer

According to an accepted manuscript published in theAmerican Journal of Roentgenology(AJR), a synoptic report improved completeness of pretreatment CT reports in patients with advanced ova
World medicine November 19,2023
Synoptic reports improve completeness of pretreatment CT reports in advanced ovarian cancer

Synoptic reports improve completeness of pretreatment CT reports in advanced ovarian cancer

According to an accepted manuscript published in theAmerican Journal of Roentgenology(AJR), a synoptic report improved completeness of pretreatment CT reports in patients with advanced ova
World medicine November 19,2023
Aspartame intake and cancer risk: What you need to know

Aspartame intake and cancer risk: What you need to know

Aspartame is a low-calorie sweetener that is approximately 200 times sweeter than sugar and is used to replace sugar and provide sweetness in energy-reduced food, or food with no added sugars. Recent
World medicine November 19,2023
Aspartame intake and cancer risk: What you need to know

Aspartame intake and cancer risk: What you need to know

Aspartame is a low-calorie sweetener that is approximately 200 times sweeter than sugar and is used to replace sugar and provide sweetness in energy-reduced food, or food with no added sugars. Recent
World medicine November 19,2023
Study examines the link between oropharyngeal cancer and high-risk sexual behavior

Study examines the link between oropharyngeal cancer and high-risk sexual behavior

The development of head and neck cancer is increasingly linked to HPV infection, which is a sexually transmitted disease. Oropharyngeal cancer is a type of head and neck cancer that is associated with
World medicine November 19,2023
Study examines the link between oropharyngeal cancer and high-risk sexual behavior

Study examines the link between oropharyngeal cancer and high-risk sexual behavior

The development of head and neck cancer is increasingly linked to HPV infection, which is a sexually transmitted disease. Oropharyngeal cancer is a type of head and neck cancer that is associated with
World medicine November 19,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com